Playside Studios (ASX: PLY) Advances To Record Revenue In Q1 FY 2024
Playside Studios (ASX: PLY) reports record quarterly revenue with growth from the higher margin Original IP division driving the growth.
Company Coverage
Ansarada Returns To Positive Operating Cash Flow In Q1 FY 2024
Ansarada (ASX: AND) is a genuine software business, but the challenge is that demand is potentially quite cyclical.
Spacetalk (ASX: SPA) Lifts Revenue Growth In Q1 FY 2024
Spacetalk (ASX: SPA) delivered strong revenue growth in Q1 FY 2024 but investors should pay closer attention to its financial health.
RPM Global (ASX: RUL) Commits To Being Better At 2023 AGM
RPM Global (ASX: RUL) will institute investor presentations after their results, including allowing shareholders to ask questions.
Cettire (ASX: CTT) Records Rapid Growth In Q1 FY 2024
Cettire (ASX: CTT) reported rapid growth in quarterly sales in Q1 FY 2024 but questions remain over scalability.
Dropsuite (ASX: DSE) Reports Record Cashflow In Q3 FY 2023
Dropsuite (ASX: DSE) reported record quarterly operating cashflow in Q3 FY 2024 and remains on a path to profitable growth.
SRG Global (ASX: SRG) and RPM Global (ASX: RUL) Update The Market
Both RPM Global (ASX: RUL) and SRG Global (ASX: SRG) are reporting strong demand from their mining clients.
Xtek (ASX: XTE) To Rename, And Shift Manufacturing
Xtek (ASX: XTE) released announcements during the week, including a plan to change its name to Highcom (ASX: HCL).
Checking In With My Austco Healthcare (ASX:AHC) Investment Thesis
Austco Healthcare (ASX: AHC) shares are up around 50% in the last 6 months. But is the investment thesis on track?
Is It Time To Buy Forager (ASX: FOR) On News They Plan To Cash Out Investors Closer To NAV?
Forager (ASX: FOR) has just announced longer term plans that would allow investors to exit much closer to net asset value…
3 Stocks With Good Momentum And Good FY 2023 Results
Each of these companies have interesting prospects and saw their share price spike on FY 2023 results.
Why I Like Resmed (ASX: RMD) During The Ozempic Panic
Here’s why the massive de-rate of the multiple on speculation about weight loss drugs reeks of panic.
Pro Medicus (ASX: PME) Shares Trade At All Time Highs After Record Contract Win
Why did the Pro Medicus share price spike to a record of $78.85 this morning and what is the relevant news for Pro Medicus (ASX: PME)?
Why Has The EML Payments Share Price Rebounded?
The EML Payments share price plunged in 2021 after the Central Bank of Ireland investigated it. So why is the EML share price up?
Medadvisor Ltd (ASX:MDR) FY23 results show progress, but problems remain
There are some tantalising aspects to the MedAdvisor (ASX: MDR) thesis, but is it a bit too risky?
SRG Global (ASX: SRG) FY 2023 Results Fail To Impress
Although the SRG Global (ASX: SRG) dividend was maintained, the second half earnings per share were a lot weaker than the first half.
Laserbond (ASX: LBL) FY 2023 Results Set Record Profit
The FY 2023 Laserbond results saw record earnings per share and a steady dividend, despite a lack of technology division sales.
Audinate (ASX: AD8) CEO Aidan Williams Sold Shares 10 Days Before Discounted Capital Raising Announced
Audinate today anounced it will raise up to $70m via a placement worth $50m and an SPP worth $20m, but the CEO sold shares 10 days ago.
An Update On The Energy One (ASX: EOL) Takeover Offer & Contract Delay
The Energy One takeover offer at $5.85 may seem more attractive now that an anticipated contract has been delayed.